NTI

2.63%

7.4¢ neurotech international limited

Ann: Medicinal Cannabis Presentation, page-4

First 4 Last

Share
Profile

Follow
Deanostock

1,415 Posts.

565

11/03/22

15:03

Post #: 60141133
Share

Originally posted by All4Info: ↑

He is still very positive, but has softened the language, last recoded presentation I saw he pretty much said the clinical trial results will be positive.. Im sure he got a roasting over the language last time (at least he should have) - But I was happy with it, showed a very strong conviction and I doubled my holding on the back of it.

I have been topping up further this week, albeit not many, but glad I have been.

Seen all this info before, nothing has changed... Just need the results.

Quotes;

1. "Will get results of the clinical trial in this march quarter"... 20 Patients..
2. "Mkt cap of $35m dollars, supposed to expected for a company yet to complete phase 1/2 studies.Those results will be ready out by the end of March. That will be the main catalyst for the growth of the company I believe, particularly if we get positive results. What a tremendous outcome if we could shew efficacy in children with autism without any side effects, which is clearly the case with cannabis, it is a very safe product."
3. "we are starting... we will be starting phase 3, on the back of positive phase 2 results. That makes us a very late stage biotech company"..
4. "CannaPacific, which are our growing partner. We are gearing up to be able to produce larger amounts of cannabis to meet the needs of our phase 3 trial and potentially nutraceutical opportunities"
5. "phase 2 results in autisim in the end of Q2.. Certainly by the end of March"...

Not sure if there is a bit of a slip up there in the Q2 (Q2 FY was December Brian)... Or Q2 CY is June.... but he reiterated March many times...

GLTAH - it sure has been slow going lately..

Expand

Not sure if there is a bit of a slip up there in the Q2 (Q2 FY was December Brian)... Or Q2 CY is June.... but he reiterated March many times...

Yeah that bit had me stumped too, couldnt really pinpint when they would share...

HAGW everyone

NTI Price at posting: 4.6¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

WGX

Westgold sets its sights on top five producer status through merger with Karora

Is oil undervalued?

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

GRX

GreenX picks up prospective copper project in Germany

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

There are more pages in this discussion • 3 more messages in this thread...

First 4 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 7.4¢		Change -0.002(2.63%)		Mkt cap ! $75.28M

Open	High	Low	Value	Volume
7.5¢	7.5¢	7.0¢	$40.05K	569.6K

Buyers (Bids)

No.	Vol.	Price($)
1	49540	7.1¢

Sellers (Offers)

Price($)	Vol.	No.
7.5¢	90000	1

View Market Depth

No.	Vol.	Price($)
1	49540	0.071
3	133849	0.070
4	88036	0.069
3	577691	0.068
2	470000	0.067

Price($)	Vol.	No.
0.075	90000	1
0.076	51138	1
0.077	42000	1
0.080	391700	3
0.081	20000	1

Last trade - 16.10pm 02/08/2024 (20 minute delay)

NTI (ASX) Chart

Ann: Medicinal Cannabis Presentation, page-4

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Westgold sets its sights on top five producer status through merger with Karora

Is oil undervalued?

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

GreenX picks up prospective copper project in Germany

Venture to sniff out high-grade REE targets at Jupiter project, WA

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Medicinal Cannabis Presentation, page-4

Top Stories

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Westgold sets its sights on top five producer status through merger with Karora

Is oil undervalued?

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

GreenX picks up prospective copper project in Germany

Venture to sniff out high-grade REE targets at Jupiter project, WA

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News